Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D03HBZ
|
||||
| Former ID |
DNC012028
|
||||
| Drug Name |
(3-Ethyl-indol-1-yl)-propyl-pyridin-4-yl-amine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [534087] | ||
| Formula |
C18H21N3
|
||||
| Canonical SMILES |
CCCN(C1=CC=NC=C1)N2C=C(C3=CC=CC=C32)CC
|
||||
| InChI |
1S/C18H21N3/c1-3-13-20(16-9-11-19-12-10-16)21-14-15(4-2)17-7-5-6-8-18(17)21/h5-12,14H,3-4,13H2,1-2H3
|
||||
| InChIKey |
KHGNFQVPPCBUSI-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Alpha-2C adrenergic receptor | Target Info | Inhibitor | [534087] | |
| Alpha-2B adrenergic receptor | Target Info | Inhibitor | [534087] | ||
| Alpha-2A adrenergic receptor | Target Info | Inhibitor | [534087] | ||
| Reactome | Adrenoceptors | ||||
| Adrenaline signalling through Alpha-2 adrenergic receptor | |||||
| Adrenaline,noradrenaline inhibits insulin secretion | |||||
| G alpha (i) signalling events | |||||
| G alpha (z) signalling events | |||||
| Surfactant metabolismR-HSA-390696:Adrenoceptors | |||||
| G alpha (z) signalling eventsR-HSA-390696:Adrenoceptors | |||||
| Surfactant metabolism | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.